The present invention relates to an
arginine deiminase
mutant with partial
lysine-deficient and preparation and application thereof. The
arginine deiminase
mutant of the present invention has enzymatic activity of degrading
arginine into citruline; compared with the
arginine deiminase with the
amino acid sequence of SEQ ID NO: 1, the
amino acid sequence comprises one or more of K9N, T, K59Q, K66R, A, K93E, A, Q, K111R, A, K119Q, L, M, K121Q, I, K122E, L, K126E, S, R, K178I, E, D, K196I, R, K209G, T, D, K243E, V, R, K249D, Q, K263N, Q, K279Y, T, K293R, H, E, K325V, I, K380T, R, E, and K406E, D, S substitutions. Compared with PEG modified natural derived
arginine deiminase, the PEG modified
arginine deiminase mutant of the present invention retain better bioactivity; and because the quantity of
lysine in arginine deiminase is reduced, the PEG modified products are more uniform and can be applied to
clinical treatment of hepatoma,
melanoma and the like.